Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Clinical equipoise, defined as the state of affairs when there is insufficient data to support one treatment over another, has recently been very much discussed and analysed. One particularly contentious issue is the usage of tissue plasminogen activator (tPA) in incidences of acute ischaemic stroke (AIS), where, as many as 40% of US emergency physicians refused to apply tPA despite the treatment being classified as a Class I recommendation in the American Heart Association (AHA) guideline.1–2 These reasons may include personal preference, reluctance to change or perhaps omission bias.3–4 This has led to Ubel's advent of the concept ‘behavioural equipoise’. Behavioural equipoise is defined as when physicians do not concur on a particular issue despite significant findings from clinical trials. Therefore, the scientific community enters into a state of stalemate. Debates can be found among neurologists and emergency room (ER) physicians all over the world, especially in Europe, the USA and Asia.5–9
Ubel argues that in a state of behavioural equipoise, further trials may be warranted. If doctors are not leveraging the therapy, then patients will not receive the best treatment. However, at least half the people will …
Competing interests The author has had short-term working experience with Boehringer Ingelheim.
Provenance and peer review Not commissioned; externally peer reviewed.
Read the full text or download the PDF:
Other content recommended for you
- Management of acute ischemic stroke
- Influence of intravenous alteplase on endovascular treatment decision-making in acute ischemic stroke due to primary medium-vessel occlusion: a case-based survey study
- Endovascular therapy of acute ischemic stroke: report of the Standards of Practice Committee of the Society of NeuroInterventional Surgery
- CODE FAST: a quality improvement initiative to reduce door-to-needle times
- Review of current and emerging therapies in acute ischemic stroke
- Question 2: Should thrombolytic agents be used in children presenting with acute ischaemic stroke?
- Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery
- Intervention in acute cerebral ischaemic stroke: a review of the role of pharmacological therapies and intra-arterial mechanical thrombectomy devices
- AHA/ASA 2018 AIS guidelines: impact and opportunity for endovascular stroke care
- Thrombolysis for acute ischaemic stroke: a new challenge for emergency medicine